Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 51,442 shares at $17.23 ($886K) on 2024-01-17, disclosed to the SEC on 2024-01-19.
Scheduled sale ($886k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.23 | 25,721 | $443K | 50.0% |
| 2 | $17.23 | 25,721 | $443K | 50.0% |
| Total | $17.23 avg | 51,442 | $886K | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |
| PLRX | SELL | 2023-04-03 | $1.9M | — | Filing → |